Literature DB >> 12128052

A non-radiolabelled ferriprotoporphyrin IX biomineralisation inhibition test for the high throughput screening of antimalarial compounds.

E Deharo1, R N García, P Oporto, A Gimenez, M Sauvain, V Jullian, H Ginsburg.   

Abstract

Intraerythrocytic malaria parasites produce large amounts of toxic ferriprotoporphyrin IX (FP) during their digestion of host cell haemoglobin. The inhibition of biomineralisation of FP to haemozoin (or beta-haematin) by antimalarial drugs underlies their mode of action. We have developed an in vitro microassay for testing the inhibition of biomineralisation by drugs. It is based on the detection by optical density measurement of solubilised beta-haematin remaining after contact with drugs. The assay uses a 192-microM haemin chloride solution in dimethyl sulfoxide, 96-well filtration microplates as well as normal microplates; it lasts 18-24h and requires a spectrophotometer. We determined by this assay the IC(50) of chloroquine phosphate (28microM) and quinine base (324microM) and showed that unlike previous methods it is insensitive to inorganic anions. We also determined the activity of synthetic dyes and plant extract to determinate the interference of coloured compounds on the accuracy of the test. We found that methylene blue, thionine (IC(50) 38 and 87microM, respectively), and an extract of plants that contains quinoline derivatives, inhibited the biomineralisation of FP regardless of their intrinsic colour.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12128052     DOI: 10.1016/s0014-4894(02)00027-9

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  12 in total

Review 1.  Antiplasmodial marine natural products in the perspective of current chemotherapy and prevention of malaria: a review.

Authors:  Dominique Laurent; Francesco Pietra
Journal:  Mar Biotechnol (NY)       Date:  2006-03-30       Impact factor: 3.619

2.  Simple colorimetric inhibition assay of heme crystallization for high-throughput screening of antimalarial compounds.

Authors:  Nguyen Tien Huy; Dinh Thanh Uyen; Atsushi Maeda; Dai Thi Xuan Trang; Tatsuo Oida; Shigeharu Harada; Kaeko Kamei
Journal:  Antimicrob Agents Chemother       Date:  2006-11-06       Impact factor: 5.191

Review 3.  Hemozoin biocrystallization in Plasmodium falciparum and the antimalarial activity of crystallization inhibitors.

Authors:  Ernst Hempelmann
Journal:  Parasitol Res       Date:  2006-11-17       Impact factor: 2.289

4.  Trioxaquines and heme-artemisinin adducts inhibit the in vitro formation of hemozoin better than chloroquine.

Authors:  Christophe Loup; Joël Lelièvre; Françoise Benoit-Vical; Bernard Meunier
Journal:  Antimicrob Agents Chemother       Date:  2007-08-13       Impact factor: 5.191

5.  2-Aminopyrimidine based 4-aminoquinoline anti-plasmodial agents. Synthesis, biological activity, structure-activity relationship and mode of action studies.

Authors:  Kamaljit Singh; Hardeep Kaur; Kelly Chibale; Jan Balzarini; Susan Little; Prasad V Bharatam
Journal:  Eur J Med Chem       Date:  2012-03-13       Impact factor: 6.514

6.  Parasitostatic effect of maslinic acid. I. Growth arrest of Plasmodium falciparum intraerythrocytic stages.

Authors:  Carlos Moneriz; Patricia Marín-García; Andrés García-Granados; José M Bautista; Amalia Diez; Antonio Puyet
Journal:  Malar J       Date:  2011-04-10       Impact factor: 2.979

7.  Effect of Inducers, Incubation Time and Heme Concentration on IC(50) Value Variation in Anti-heme Crystallization Assay.

Authors:  Nguyen Thanh Thuy Nhien; Nguyen Tien Huy; Dinh Thanh Uyen; Eric Deharo; Pham Thi Le Hoa; Kenji Hirayama; Shigeharu Harada; Kaeko Kamei
Journal:  Trop Med Health       Date:  2011-12-21

8.  Biological activities of nitidine, a potential anti-malarial lead compound.

Authors:  Jérome Bouquet; Marion Rivaud; Séverine Chevalley; Eric Deharo; Valérie Jullian; Alexis Valentin
Journal:  Malar J       Date:  2012-03-09       Impact factor: 2.979

Review 9.  Development in Assay Methods for in Vitro Antimalarial Drug Efficacy Testing: A Systematic Review.

Authors:  Shweta Sinha; Phulen Sarma; Rakesh Sehgal; Bikash Medhi
Journal:  Front Pharmacol       Date:  2017-10-23       Impact factor: 5.810

10.  New 1-aryl-3-substituted propanol derivatives as antimalarial agents.

Authors:  Silvia Pérez-Silanes; Luis Berrade; Rory N García-Sánchez; Adela Mendoza; Silvia Galiano; Berta Martín Pérez-Solórzano; Juan J Nogal-Ruiz; Antonio R Martínez-Fernández; Ignacio Aldana; Antonio Monge
Journal:  Molecules       Date:  2009-10-14       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.